Chemical Compound
Bictegravir sodium
CAS Registry Number
1807988-02-8
Primary Record
Bictegravir sodium
- In stock
- 3,829 g
- Purity
- 99.3 %
- CAS
- 1807988-02-8
Compound Identifiers & Properties
- CAS
- 1807988-02-8
- PubChem CID
- 102593990
- SMILES
- C1C[C@@H]2C[C@H]1N3[C@H](O2)CN4C=C(C(=O)C(=C4C3=O)[O-])C(=O)NCC5=C(C=C(C=C5F)F)F.[Na+]
- Canonical SMILES
- O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c([O-])c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2.[Na+]
Names & Synonyms
- Bictegravir sodium
- GS-9883 sodium
- Bictegravir (sodium)
- 1807988-02-8
- GS-9883-01 sodium
- Bictegravir sodium [USAN]
- RefChem:568042
- 4L5MP1Y7W7
- UNII-4L5MP1Y7W7
- C21H17F3N3NaO5
- CHEBI:172961
- DTXSID401027938
- orb1694663
- BICTEGRAVIR SODIUM [MI]
- Bictegravir sodium (JAN/USAN)
- BICTEGRAVIR SODIUM [JAN]
- CHEMBL3989867
- SCHEMBL19991461
- WJNFBIVCQMPPJC-FQYDJHLKSA-M
- DTXCID601513505
- BCP20910
- BICTEGRAVIR SODIUM [WHO-DD]
- HXC98802
- HY-17605A
- AKOS040754592
- GS-9883
- BICTEGRAVIR SODIUM [ORANGE BOOK]
- BIKTARVY COMPONENT BICTEGRAVIR SODIUM
- AC-30681
- DA-51106
- CS-0380750
- GS-9883-01
- D10910
- N16970
- A904622
- sodium;(1S,11R,13R)-3,6-dioxo-7-[(2,4,6-trifluorophenyl)methylcarbamoyl]-12-oxa-2,9-diazatetracyclo[11.2.1.02,11.04,9]hexadeca-4,7-dien-5-olate
- Q27259952
- B2693-343857
- (2R,5S,13aR)-8-Hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide sodium salt
- Bictegravir sodium|1807988-02-8|Bictegravir (sodium)|UNII-4L5MP1Y7W7|4L5MP1Y7W7|sodium
- GS-9883; GS 9883; GS9883; GS-9883-01; GS9883-01; GS 9883-01
- (2R,5S,13aR)-8-Hydroxy-7,9-dioxo-N-((2,4,6-trifluorophenyl)methyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazepine-10-carboxamide monosodium salt
- (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide monosodium salt
- 2,5-Methanopyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazepine-10-carboxamide, 2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-N-((2,4,6-trifluorophenyl)methyl)-, sodium salt (1:1), (2R,5S,13aR)-
- 2,5-Methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, 2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-, sodium salt (1:1), (2R,5S,13aR)-
- Bictegravir sodium salt; Sodium Bictegravir; 2,5-Methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, 2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-, sodium salt (1:1), (2R,5S,13aR)-; GS 9883-01; (2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-hydroxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide sodium salt
- Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1, 3]oxazepin-8-olate
- sodium (2R,5S,13aR)-7,9-dioxo-10-[(2,4,6-trifluorobenzyl)carbamoyl]-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate